Cancer Database Query Results

Scientific Papers found: Click to Expand⟱
4064- FA,  VitB6,  VitB12,    High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial
- Trial, AD, NA
*Hcy/homoC↓, *cognitive∅,
4074- FA,  VitB12,    Associations between Alzheimer's disease and blood homocysteine, vitamin B12, and folate: a case-control study
- Trial, AD, NA
*cognitive↑, *Hcy/homoC↓, *other↝, *other↝,
4044- FA,    Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial
- Trial, AD, NA
*Hcy/homoC↓, *memory↑, *cognitive↑,
6870- FA,    Folic acid supplementation improves cognitive function in participants with cerebral small vascular disease-related cognitive impairment: a randomized controlled trial
- Trial, AD, NA
*Dose↝, *cognitive↑, *Hcy/homoC↓, *MMP9↓, *Risk↓,
6884- FA,    Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trial
- Trial, AD, NA
*cognitive↑, *Aβ↓, *BP↓, *SAM-e↓, *DNMT3A↑,
6867- FA,  Ang,    Effect of Feru-guard 100M on amyloid-beta deposition in individuals with mild cognitive impairment
- Trial, AD, NA
*Aβ∅, *BrainVol∅, *cognitive∅,
6866- FA,  Ang,    Effects of Ferulic Acid and Angelica archangelica Extract (Feru-guard ®) on Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Prospective Trial
- Trial, AD, NA
*cognitive↑, *neuroP↑, *AChE↓, *Dose↝, *Aβ↓,
6883- FA,  Ang,    Effect of ferulic acid and Angelica archangelica extract on behavioral and psychological symptoms of dementia in frontotemporal lobar degeneration and dementia with Lewy bodies
- Trial, AD, NA
*Dose↝, *neuroP↑,
6962- FA,  VitB12,    Effects of Folic Acid and Vitamin B12, Alone and in Combination on Cognitive Function and Inflammatory Factors in the Elderly with Mild Cognitive Impairment: A Single-blind Experimental Design
- Trial, AD, NA
*Hcy/homoC↝, *IL6↓, *TNF-α↓, *MCP1/CCL2↝, *eff↑, *cognitive↑, *Inflam↓,
6951- FA,    Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI
- Trial, AD, NA
*Dose↝, *cognitive↑, *Hcy/homoC↓, *IL6↓, *TNF-α↓,
6950- FA,  VitB12,    Effects of Folic Acid and Vitamin B12 Supplementation on Cognitive Impairment and Inflammation in Patients with Alzheimer's Disease: A Randomized, Single-Blinded, Placebo-Controlled Trial
- Trial, AD, NA
*Dose↝, *cognitive?,
6949- FA,  VitB12,    A controlled trial of homocysteine lowering and cognitive performance
- Trial, AD, NA
*Hcy/homoC↓, *cognitive∅,
6948- FA,  VitB12,    A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people
- Trial, AD, NA
*Dose↝, *Hcy/homoC↓, *cognitive∅,
6947- FA,    Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
- Trial, AD, NA
*Hcy/homoC↓, *cognitive↑,
6954- FA,    Folic acid as a potential therapeutic agent for Alzheimer's disease: Effects on inflammatory cytokines, amyloid deposition, and neurotransmitter metabolism
- Trial, AD, NA
*Inflam↓, *Aβ↓, *IL1β↓, *IL6↓, *TNF-α↓, *tau↓, *GABA↑, *5HT↑, *Ach↑, *Albumin↑, *HemoG↑, *neuroP↑, *Hcy/homoC↓,
6956- FA,  VitB12,    A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients
- Trial, AD, NA
*Dose↝, *Hcy/homoC↓, *cognitive↑, *eff↓,
6961- FA,  VitB12,  VitB6,  Silicon,  Alum  B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment
- Trial, AD, NA
*BrainVol↝, *cognitive↝, *cognitive↑, *Dose↝, *other↝, *Hcy/homoC↓, *Risk↓, *BrainVol∅, *BrainVol↑, *other↝, *cognitive↑, *cognitive↑, *other↝, *Risk↝,
1914- Fer,  VitC,  TMZ,  Rad,    Pharmacologic Ascorbate and Ferumoxytol Combined with Temozolomide and Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma
- Trial, GBM, NA
eff↑,
6920- FIS,    A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design
- Trial, BC, NA
Dose↝, cellSen?,
6876- Flav,    Flavonoid-rich orange juice is associated with acute improvements in cognitive function in healthy middle-aged males
- Trial, AD, NA
*cognitive↑, *motorD↑, *other?,
4121- FLS,    Sensory-Evoked 40-Hz Gamma Oscillation Improves Sleep and Daily Living Activities in Alzheimer’s Disease Patients
- Trial, AD, NA
*cognitive↑, *Sleep↑,
6931- FLS,    Gamma frequency sensory stimulation in mild probable Alzheimer's dementia patients: Results of feasibility and pilot studies
- Trial, AD, NA
*tau↓, *Aβ↓, *other↝, *other↑, *memory↑, *other↑,
6933- FLS,  AudGS,    Gamma sensory stimulation in mild Alzheimer's dementia: An open-label extension study
- Trial, AD, NA
*Dose↝, *toxicity↓, *cognitive↑,
6932- FLS,    Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study
- Trial, AD, NA
*toxicity↓,
8307- FS,  lign,    Efficacy and safety of a flaxseed hull extract in the symptomatic management of benign prostatic hyperplasia: a parallel, randomized, double-blind, placebo-controlled, pilot study
- Trial, BPH, NA
*Dose↝, *IPSS↓, *toxicity↓, *QoL↑, *other↝,
8304- FS,    Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer
- Trial, Pca, NA
NF-kB↓, VEGF↓, Ki-67↓, TumCP↓,
8303- FS,    The relative bioavailability of enterolignans in humans is enhanced by milling and crushing of flaxseed
- Trial, Nor, NA
*Dose?, *BioAv↑,
8310- FS,    Can flaxseed “milk” prevent anthracycline mediated cardiotoxicity in women with breast cancer (CANFLAX-BC)?
- Trial, BC, NA
cardioP↑,
8300- FS,    Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery
- Trial, Pca, NA
Dose↝, TumCP↓, Ki-67↓, *toxicity↓, Ingr↑, testos↓, DHT↓, Risk↓, Dose↝,
8315- FS,    Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen
- Trial, Pca, NA
PSA↓,
7015- Fuc,    Effects of Ingesting Fucoidan Derived from Cladosiphon okamuranus Tokida on Human NK Cells: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Pilot Study
- Trial, Nor, NA
*NK cell↑, *toxicity↓,
7018- Fuc,    Absorption Study of Mozuku Fucoidan in Japanese Volunteers
- Trial, Nor, NA
*Dose↝, *BioAv↝, *eff↝, *Inflam↓, *AntiThr↑, angioG↓, *AntiViral↑, *AntiTum↑, *antiOx↓, *BioAv↝,
7023- Fuc,    The Use of Oligo Fucoidan in Cancer Bearing Dogs Undergoing Chemotherapy: A Double-Blinded Study
- Trial, Var, NA
QoL∅, QoL↑,
7001- Fuc,    Fucoidan reduces the toxicities of chemotherapy for patients with unresectable advanced or recurrent colorectal cancer
- Trial, CRC, NA
fatigue↓, eff↑, OS↑,
7000- Fuc,    Efficacy of Low-Molecular-Weight Fucoidan as a Supplemental Therapy in Metastatic Colorectal Cancer Patients: A Double-Blind Randomized Controlled Trial
- Trial, CRC, NA
DCR↑, OS∅, PFS∅, ORR∅, AEs∅, QoL∅,
6999- Fuc,    Fucoidan Improves Tumour Control and Liver Function in TACE for Unresectable Hepatocellular Carcinoma: A Randomised Trial
- Trial, HCC, NA
hepatoP↑, toxicity↓,
7002- Fuc,    The Auxiliary Effects of Low-Molecular-Weight Fucoidan in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy Before Surgery: A Double-Blind, Randomized, Placebo-Controlled Study
- Trial, CRC, NA
fatigue↓, GutMicro↑,
7040- GA,    Effects of gallic acid on acrylamide-induced endoplasmic reticulum stress, neuroinflammation and neuronal apoptosis in rats
- Trial, AD, NA
*SOD↑, *GSH↑, *GPx↑, *Catalase↑, *MDA↓, *TNF-α↓, *IL1β↓, *BAX↓, *Casp3↓, *BDNF↑, *NRF2↑, *HO-1↑,
7072- GABA,  CHOC,    Psychological stress-reducing effect of chocolate enriched with gamma-aminobutyric acid (GABA) in humans: assessment of stress using heart rate variability and salivary chromogranin A
- Trial, Nor, NA
*Dose↝, *Stress↓,
7071- GABA,    Oral intake of γ-aminobutyric acid affects mood and activities of central nervous system during stressed condition induced by mental tasks
- Trial, Nor, NA
*memory↑, *BP↓, *Dose↝, *Stress↓,
7075- GABA,    Effects of γ-aminobutyric acid supplementation on glucose control in adults with prediabetes: A double-blind, randomized, placebo-controlled trial
- Trial, Diabetic, NA
*Dose↝, *glucose∅,
7074- GABA,    Effect of oral γ-aminobutyric acid (GABA) administration on sleep and its absorption in humans
- Trial, Nor, NA
*Sleep↑,
7076- GABA,    Anti-hypertensive effect of gamma-aminobutyric acid (GABA)-rich Chlorella on high-normal blood pressure and borderline hypertension in placebo-controlled double blind study
- Trial, Nor, NA
*Dose↝, *BP↓, *eff↑,
7077- GABA,    GABA Supplementation, Increased Heart-Rate Variability, Emotional Response, Sleep Efficiency and Reduced Depression in Sedentary Overweight Women Undergoing Physical Exercise: Placebo-Controlled, Randomized Clinical Trial
- Trial, Nor, NA
*Sleep↑, *Dose↝, *other↝,
7073- GABA,    Safety and Efficacy of Gamma-Aminobutyric Acid from Fermented Rice Germ in Patients with Insomnia Symptoms: A Randomized, Double-Blind Trial
- Trial, Nor, NA
*Sleep↑,
7061- GamB,    An open-labeled, randomized, multicentered, phase IIa study for advanced cancer treatment by gambogic acid injection (THS)
- Trial, Var, NA
ORR↑, DCR↑, *toxicity↓,
7054- GamB,    An open-labeled, randomized, multicenter phase IIa study of gambogic acid injection for advanced malignant tumors
- Trial, Var, NA
Dose↝, DCR↝,
7187- GBE,    Ginkgo biloba for prevention of dementia: a randomized controlled trial
- Trial, AD, NA
*Dose↝, Risk∅, eff∅,
7188- GBE,    Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial
- Trial, AD, NA
*Dose↝, *cognitive↑,
7189- GBE,    Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx]
- Trial, NA, NA
*Dose↝, *toxicity↓,

Showing Research Papers: 151 to 200 of 435
Prev Page 4 of 9 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 435

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

2/16-OHE1↑, 1,   8-oxo-dG↓, 1,   ADCY4↑, 1,   AEs∅, 1,   APG↓, 2,   CIT↓, 1,   CR↑, 2,   DCR↑, 3,   DCR↝, 1,   ENL↑, 1,   IGF-2R↑, 1,   Ingr↑, 1,   JAG1↑, 1,   LC↑, 1,   mal↓, 1,   miR-106b↓, 1,   Mucositis↓, 4,   Nausea↓, 4,   Nausea∅, 2,   NEU1↑, 1,   NLR↓, 1,   ORR↑, 3,   ORR∅, 1,   PC↑, 3,   PFS↑, 4,   PFS∅, 1,   PGI2↓, 1,   RBC↑, 3,   RFS↑, 1,   TTP↑, 1,   UFR↑, 1,   Vomit↓, 4,   Vomit∅, 2,   WBC↑, 2,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 2,   Bil∅, 1,   Copper↓, 2,   CoQ10↑, 1,   GSH↓, 1,   MDA↓, 1,   ROS↓, 3,   ROS↑, 5,   ROS↝, 2,   SOD↑, 1,   TrxR↓, 1,   VitC↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

selm↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

BCR-ABL↓, 1,   Insulin↓, 2,   MPT↑, 1,   PGC-1α↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ALAT↓, 2,   BUN↓, 1,   CYP3A4⇅, 1,   FAO↑, 1,   lactateProd↓, 1,   PDK1 / PDPK1↓, 2,   PPARγ↓, 1,  

Cell Death(tgid=5) ⓘ

p‑Akt↓, 1,   Apoptosis↑, 6,   Bcl-2↓, 3,   Bcl-xL↓, 2,   Cyt‑c↝, 1,   IAP1↓, 1,   Mcl-1↓, 3,   Myc↓, 1,   NOXA↑, 1,   PUMA↑, 1,   survivin↓, 1,   TRPV1↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

miR-30a-5p↑, 1,   other?, 1,   other↓, 4,   other↑, 6,   other↝, 18,   other∅, 3,   SD↑, 4,  

Autophagy & Lysosomes(tgid=9) ⓘ

TumAuto↓, 1,   TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

NKX3.1↓, 1,   P53↑, 1,   RAD51↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

cycD1/CCND1↓, 2,   P21↑, 3,   TumCCA↑, 5,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 1,   CSCs↓, 2,   HDAC↓, 4,   HH↓, 3,   HH∅, 1,   IGF-1↓, 7,   IGF-1↑, 1,   IGFBP1↑, 2,   IGFBP3↓, 1,   IGFBP3↑, 1,   IGFR↓, 1,   NOTCH3↑, 1,   PI3K↓, 1,   PTEN↑, 2,   Smo↓, 1,   TumCG↓, 7,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

5LO↓, 1,   AntiAg↑, 1,   AntiAg↝, 1,   AntiAg∅, 1,   Ca+2↓, 1,   Ca+2↑, 1,   GLI3↓, 1,   Ki-67↓, 6,   miR-19b↓, 1,   miR-29b↑, 1,   MMP2↓, 1,   MMP9↓, 2,   MMP9:TIMP1↑, 1,   Slug↓, 1,   p‑SMAD2↓, 1,   p‑SMAD3↓, 1,   TGF-β↓, 1,   TIMP1↓, 1,   TumCA↓, 1,   TumCI↓, 3,   TumCMig↓, 2,   TumCP↓, 9,   TumMeta↓, 1,   TumMeta↑, 1,   Twist↓, 1,   Vim↓, 1,   ZO-1↓, 1,   β-catenin/ZEB1↓, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 8,   angioG∅, 1,   EGFR↓, 3,   Endoglin↓, 1,   Hif1a↓, 1,   VEGF↓, 3,   VEGFR2/KDR/Flk1↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   IBI↑, 1,   P-gp/ABCB1↓, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD14↓, 1,   CD25+↓, 1,   CD4+↓, 1,   CD4+↑, 1,   cellSen?, 1,   COX2/PTGS2↓, 4,   COX2/PTGS2∅, 1,   CRP↓, 2,   FoxP3+↓, 1,   GM-CSF↓, 1,   IFN-γ↑, 1,   IL10↓, 1,   IL12↓, 1,   IL18↑, 1,   IL1β↓, 1,   IL1β∅, 1,   IL22↓, 1,   IL6↓, 4,   Imm↑, 11,   INF-γ↝, 1,   Inflam↓, 7,   LIF↑, 1,   MCP1/CCL2↓, 1,   Neut↓, 1,   Neut↑, 2,   NF-kB↓, 2,   NK cell↑, 4,   PDT+↓, 1,   PGE2↓, 2,   PSA↓, 10,   T-Cell↑, 1,   TNF-α↓, 1,   TNF-α∅, 1,   VitD↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 2,   AR↝, 1,   DHT↓, 1,   EstroRS/ERS↑, 1,   testos↓, 1,   testos∅, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 2,   BioAv↑, 9,   BioAv↝, 8,   BioEnh↑, 1,   ChemoSen↑, 6,   ChemoSen∅, 1,   CYP1A2↑, 1,   Dose?, 2,   Dose↓, 3,   Dose↑, 7,   Dose↝, 117,   Dose∅, 4,   eff↓, 2,   eff↑, 42,   eff↝, 6,   eff∅, 7,   Half-Life↑, 1,   Half-Life↝, 6,   RadioS↑, 4,   selectivity↑, 5,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   ALC↓, 1,   AR↓, 2,   AR↝, 1,   AST↓, 2,   BG↓, 1,   Bil∅, 1,   CA125↓, 1,   CA125∅, 1,   CA19-9↓, 1,   CEC↝, 1,   creat↓, 1,   CRP↓, 2,   CTC↓, 1,   EGFR↓, 3,   EstroRS/ERS↑, 1,   GutMicro↑, 1,   HemoG↑, 1,   IL6↓, 4,   Ki-67↓, 6,   Myc↓, 1,   PSA↓, 10,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 1,   AntiCan↑, 6,   antiNeop↑, 1,   AntiTum↑, 3,   AntiTum∅, 1,   cachexia↓, 1,   cardioP↑, 3,   CardioT↑, 1,   CardioT↝, 1,   chemoP↑, 6,   chemoP∅, 1,   chemoPv↑, 5,   ChemoSideEff↓, 2,   fatigue↓, 3,   hepatoP↓, 1,   hepatoP↑, 2,   memory↑, 1,   NP/CIPN↓, 2,   NP/CIPN↑, 3,   Obesity↓, 1,   OS?, 1,   OS↑, 48,   OS↝, 1,   OS∅, 9,   Pain↓, 8,   QoL↑, 16,   QoL∅, 3,   radioP?, 1,   radioP↑, 5,   radioP↝, 1,   Remission↑, 3,   Risk↓, 13,   Risk↑, 2,   Risk↝, 2,   Risk∅, 4,   stomatitis↓, 1,   Strength↑, 1,   Strength∅, 1,   toxicity↓, 25,   toxicity↑, 1,   toxicity↝, 19,   toxicity∅, 1,   TumVol↓, 4,   TumW↓, 1,   Weight↑, 5,   Weight∅, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

CD8+↑, 3,   Diar↓, 1,   Diar⇅, 1,   Inf↓, 4,   Sepsis↓, 1,  
Total Targets: 277

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

12-HETE↓, 1,   2/16-OHE1↑, 1,   5-HETE↓, 1,   AcOH↑, 2,   AntiBio↑, 2,   BDI↓, 1,   Buty↑, 3,   CCr / CrCl↓, 1,   CCr / CrCl∅, 1,   Eic↓, 1,   END↑, 1,   ENL↑, 1,   Eos↓, 1,   FEV1↑, 2,   FFA/NEFA↝, 1,   HRV↑, 1,   IgE↓, 1,   Ingr↝, 1,   IPSS↓, 1,   Learn↑, 1,   NLR↓, 1,   NMSS↓, 1,   PA↑, 2,   PCO↓, 1,   PEF↑, 1,   rHR↓, 1,   RT↓, 2,   SCFAs↑, 3,   SCFAs∅, 1,   Stress↓, 4,   Tinn↓, 1,   TMAO∅, 1,   UFR↑, 1,   UPDRS↓, 1,   UPDRSIII∅, 1,   UR↓, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 11,   Bil↓, 2,   Catalase↑, 1,   GPx↑, 1,   GSH↑, 5,   HDL↓, 2,   HDL↑, 4,   HO-1↑, 1,   Iron↓, 1,   lipid-P↓, 2,   MDA↓, 4,   MDA↑, 1,   MPOD↑, 2,   NRF2↑, 2,   ROS↓, 16,   SAM-e↓, 1,   SOD↑, 3,   TAC↑, 3,   TBARS↓, 1,   uricA↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

mitResp↑, 1,   mtDam↓, 1,   PGC-1α↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ACLY↓, 1,   adiP↑, 1,   ALAT↓, 3,   ALAT∅, 1,   AMPK↑, 1,   CRM↑, 1,   DHA↑, 2,   glucose∅, 1,   KeyT↝, 1,   lactateProd↓, 1,   LDH↓, 3,   LDL↓, 9,   NH3↓, 1,   SIRT1↑, 1,  

Cell Death(tgid=5) ⓘ

BAX↓, 1,   Casp3↓, 1,   CK2↓, 1,   p38↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

Ach↑, 2,   AntiThr↑, 3,   other?, 3,   other↓, 3,   other↑, 16,   other↝, 14,   other∅, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,   DNArepair↑, 1,   DNMT3A↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Choline↑, 1,   Diff↝, 1,   EP2↑, 1,   HDAC3↓, 1,   IGF-1↓, 1,   IGF-1↑, 1,   IGFBP3↓, 1,   NOTCH↓, 1,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 4,   AntiAg∅, 1,   MMP9↓, 1,   TGF-β↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

NO↓, 1,   TXA2↓, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   IBI↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD14↑, 1,   COX1↓, 1,   CRP↓, 4,   IFN-γ↓, 1,   IFN-γ↑, 3,   IL1↓, 1,   IL10↓, 1,   IL10↑, 1,   IL10∅, 1,   IL12↓, 1,   IL17∅, 1,   IL1β↓, 5,   IL4↑, 1,   IL4∅, 1,   IL6↓, 9,   IL8↓, 1,   Imm↑, 5,   Inflam↓, 23,   MCP1/CCL2↓, 1,   MCP1/CCL2↝, 1,   NF-kB↓, 1,   NK cell↑, 3,   PGE2↓, 2,   PSA↓, 1,   TNF-α↓, 8,   TNF-α↑, 3,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 3,   AChE↓, 4,   BDNF↑, 7,   BDNF∅, 1,   BrainVol↑, 1,   BrainVol↝, 1,   BrainVol∅, 3,   GABA↑, 1,   tau↓, 3,   p‑tau↓, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 10,   Aβ∅, 1,   BACE/β-secretase↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

cortisol↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 4,   BioAv↑, 18,   BioAv↝, 12,   Dose?, 6,   Dose↓, 1,   Dose↑, 7,   Dose↝, 111,   eff↓, 1,   eff↑, 21,   eff↝, 7,   eff∅, 1,   Half-Life↓, 2,   Half-Life↑, 2,   Half-Life↝, 19,   P450↓, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 3,   ALAT∅, 1,   Albumin↑, 2,   ALP↓, 1,   AST↓, 1,   AST∅, 1,   Bil↓, 2,   BloodF↑, 3,   BMD↑, 1,   BP↓, 12,   BP∅, 1,   CRP↓, 4,   GutMicro↑, 6,   GutMicro∅, 1,   Hcy/homoC↓, 13,   Hcy/homoC↝, 1,   HemoG↑, 1,   hs-CRP↓, 1,   IL6↓, 9,   LDH↓, 3,   PSA↓, 1,   TG/TAG↓, 1,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   AntiCan↑, 2,   AntiDiabetic↑, 2,   AntiTum↑, 3,   ANXi↓, 2,   cardioP↑, 5,   chemoP↑, 3,   cognitive?, 1,   cognitive↓, 1,   cognitive↑, 68,   cognitive↝, 2,   cognitive∅, 12,   fatigue↓, 2,   GFR↓, 1,   GFR∅, 1,   hepatoP↑, 5,   memory↑, 23,   memory∅, 1,   Mood↑, 7,   motorD↑, 9,   MusCon↓, 1,   neuroP↑, 12,   Obesity↓, 2,   Pain↓, 8,   QoL?, 1,   QoL↑, 10,   RenoP↑, 3,   Risk↓, 5,   Risk↑, 2,   Risk↝, 1,   Sleep↑, 6,   Strength↑, 4,   toxicity?, 1,   toxicity↓, 31,   toxicity↑, 1,   toxicity↝, 3,   toxicity∅, 7,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiFungal↑, 2,   AntiViral↑, 4,   Bacteria↓, 2,  
Total Targets: 227

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page